Semnur Pharmaceuticals competitorsClear all

Semnur Pharmaceuticals's top competitors include Aptuit, Fortress Biotech, TiGenix and BioCryst Pharmaceuticals.
Semnur Pharmaceuticals
Semnur Pharmaceuticals
Semnur Pharmaceutical develops pharmaceutical products.
Aptuit
Aptuit
Aptuit is a pharmaceutical services company that delivers early discovery to mid-phase drug development solutions.
Fortress Biotech
Fortress Biotech
Fortress Biotech, Inc. is a biopharmaceutical company dedicated to acquiring, developing and commercializing novel pharmaceutical and biotechnology products.
TiGenix
TiGenix
TiGenix NV is a leading European cell therapy company with an advanced clinical stage pipeline of adult stem cell programmes.
BioCryst Pharmaceuticals
BioCryst Pharmaceuticals
BioCryst Pharmaceuticals designs, optimizes and develops novel small-molecule drugs that block key enzymes to treat rare diseases.
Founding Date
Founding Date
2013
Founding Date
1993
Founding Date
2006
Founding Date
2000
Founding Date
1986
Type
Type
Subsidiary
Type
Subsidiary
Type
Public
Type
Subsidiary
Type
Public
Tags
Locations
Locations
Mountain View, US HQ
Locations
Greenwich, US HQ
Verona, IT
Reinach, CH
Milton, GB
Locations
New York, US HQ
Waltham, US
Locations
Leuven, BE HQ
Locations
Durham, US HQ
Hoover, US
Employees
Employees
420% decrease
Employees
954
Employees
936% increase
Employees
623% decrease
Employees
14040% increase
Valuation ($)
Valuation ($)
N/A
Valuation ($)
N/A
Valuation ($)
371.5 m
Valuation ($)
N/A
Valuation ($)
642.7 m
Twitter followers
Twitter followers
N/A
Twitter followers
949
Twitter followers
12.5 k
Twitter followers
N/A
Twitter followers
754
Alexa Website Rank
Alexa Website Rank
N/A
Alexa Website Rank
355000
Alexa Website Rank
224639
Alexa Website Rank
N/A
Alexa Website Rank
247983
Employee Rating
Employee Rating
N/A
Employee Rating
2.7
Employee Rating
N/A
Employee Rating
4.2
Employee Rating
4

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
N/A
Revenue (est.)
$36.6m (FY, 2019)
Revenue (est.)
N/A
Revenue (est.)
$48.8m (FY, 2019)
Cost of goods
Cost of goods
N/A
Cost of goods
N/A
Cost of goods
$10.5m (FY, 2019)
Cost of goods
N/A
Cost of goods
$3.7m (FY, 2019)
Gross profit
Gross profit
N/A
Gross profit
N/A
Gross profit
$26.1m (FY, 2019)
Gross profit
N/A
Gross profit
$45.1m (FY, 2019)
Net income
Net income
N/A
Net income
N/A
Net income
($101.7m) (FY, 2019)
Net income
N/A
Net income
($108.9m) (FY, 2019)

Funding

Total funding raised
Total funding raised
$ 6m
Total funding raised
N/A
Total funding raised
N/A
Total funding raised
$ 37.5m
Total funding raised
$ 1.9m
For sources of this data, please see the company profile

View company profiles

Aptuit
HQ
Greenwich, US

Aptuit is a pharmaceutical services company that delivers early discovery to mid-phase drug development solutions.

View company
Fortress Biotech
HQ
New York, US
Employees
93↑ 6% increase

Fortress Biotech, Inc. is a biopharmaceutical company dedicated to acquiring, developing and commercializing novel pharmaceutical and biotechnology products.

View company
TiGenix
HQ
Leuven, BE

TiGenix NV is a leading European cell therapy company with an advanced clinical stage pipeline of adult stem cell programmes.

View company
BioCryst Pharmaceuticals
HQ
Durham, US
Employees
140↑ 40% increase

BioCryst Pharmaceuticals designs, optimizes and develops novel small-molecule drugs that block key enzymes to treat rare diseases.

View company